Dr. Philippe Cassier, MD, PhD
Claim this profileCentre Léon Bérard
Expert in Solid Tumors
Studies Pancreatic Cancer
18 reported clinical trials
32 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
RET positive
2Pancreatic Cancer
Stage IV
Stage III
FGFR1 positive
Clinical Trials Philippe Cassier, MD, PhD is currently running
GSK5764227
for Advanced Cancer
The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of GSK5764227. The study will also see how the levels of GSK5764227 will change over time at different dose amounts when administered alone and in combination with other medicines like carboplatin, cisplatin, atezolizumab, pembrolizumab, durvalumab, bevacizumab, cetuximab.
Recruiting1 award Phase 12 criteria
TNG462
for Solid Cancers
This trial is testing a new oral drug called TNG462 in patients with advanced or metastatic solid tumors that have an MTAP deletion. The drug works by blocking a protein that helps these cancer cells grow. The goal is to see if TNG462 can stop the cancer from growing and spreading.
Recruiting1 award Phase 1 & 2
More about Philippe Cassier, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 18 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Philippe Cassier, MD, PhD has experience with
- Pembrolizumab
- Mitazalimab
- PBI-200
- TPX-0022
- KIN-2787
- TNG462
Breakdown of trials Philippe Cassier, MD, PhD has run
Pancreatic Cancer
Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Philippe Cassier, MD, PhD specialize in?
Philippe Cassier, MD, PhD focuses on Solid Tumors and Pancreatic Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Philippe Cassier, MD, PhD currently recruiting for clinical trials?
Yes, Philippe Cassier, MD, PhD is currently recruiting for 3 clinical trials in Lyon Rhone. If you're interested in participating, you should apply.
Are there any treatments that Philippe Cassier, MD, PhD has studied deeply?
Yes, Philippe Cassier, MD, PhD has studied treatments such as Pembrolizumab, Mitazalimab, PBI-200.
What is the best way to schedule an appointment with Philippe Cassier, MD, PhD?
Apply for one of the trials that Philippe Cassier, MD, PhD is conducting.
What is the office address of Philippe Cassier, MD, PhD?
The office of Philippe Cassier, MD, PhD is located at: Centre Léon Bérard, Lyon, Rhone 69008 France. This is the address for their practice at the Centre Léon Bérard.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.